Year: 2004 Source: Current Psychiatry, v.3, no.10, (October 2004), p.12, 15-18, & 23 SIEC No: 20080148

This commentary provides a perspective on Columbia University’s report on classifying suicidality in selective serotonin reuptake inhibitor clinical trial data, how undisclosed clinical trial data tipped the risk-benefit balance in pediatric patients, & new data for using these drugs plus psychotherapy with adolescents with depression. (23 refs.)